12 Results for "

KLF5

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "KLF5" in MCE Product Catalog:

  • Targets Recommended:
16
16 Publications Verification
Cat. No.: HY-19994
CAS No.: 1550008-55-3
Target:  

KLF

Research Areas:  

Cancer

ML264 is an antitumor agent that potently and selectively inhibits Krüppel-like factor five (KLF5) expression.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136530
CAS No.: 2505001-62-5
Purity:  99.61%
Target:  

KLF

Research Areas:  

Cancer

SR18662 is a potent inhibitor of Krüppel-like factor five (KLF5) with an IC50 of 4.4 nM and an analogue of ML264 (HY-19994) with improved inhibitory potency against colorectal cancer cells. SR18662 can be used for the study of colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W011044
CAS No.: 749872-43-3
Target:  

KLF

Research Areas:  

Cancer

CID 5951923 is a potent inhibitor of Krüppel-like factor 5 (KLF5), with an IC50 of 603 nM. CID 5951923 can inhibit proliferation of cancer cells in vitro .
loading...
    loading...
Cat. No.: HY-N1570
CAS No.: 34175-96-7
Pterosin B is an orally active indanone. Pterosin B can be obtained from Pteridium aquilinum. Pterosin B is a Sik3 signaling inhibitor. Pterosin B inhibits Klf5 expression and reduces β-amyloid deposition. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice. Pterosin B inhibits cardiomyocyte hypertrophy, improves cognitive impairment, and lowers blood glucose. Pterosin B can be used in research on arthritis, Alzheimer's disease, pathological cardiac hypertrophy and diabetes [5].
loading...
    loading...
Cat. No.: HY-139691
CAS No.: 2505001-54-5
Purity:  99.95%
Target:  

KLF

Research Areas:  

Cancer

SR15006 is a inhibitor of Krüppel-like factor 5 (KLF5) with an IC50 of 41.6 nM in DLD-1/pGL4.18hKLF5p cells) .
loading...
    loading...
Cat. No.: HY-RS07342
Research Areas:  

Others

KLF5 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23111
Research Areas:  

Others

Klf5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Klf5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16676
Research Areas:  

Others

Klf5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Klf5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-169213
CAS No.: 2991822-04-7
Target:  

KLF RAD51

Research Areas:  

Cancer

LN-439A (compound LN-439A) is a BAP1 inhibitor that inhibits the growth of basal-like breast cancer by degrading KLF5. .
loading...
    loading...
Cat. No.: HY-N1570R
CAS No.: 34175-96-7
Pterosin B (Standard) is the analytical standard of Pterosin B (HY-N1570). This product is intended for research and analytical applications. Pterosin B is an indanone. Pterosin B can be obtained from Pteridium aquilinum. Pterosin B is a Sik3 signaling inhibitor. Pterosin B inhibits Klf5 expression and reduces β-amyloid deposition. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice. Pterosin B inhibits cardiomyocyte hypertrophy, improves cognitive impairment, and lowers blood glucose. Pterosin B can be used in research on arthritis, Alzheimer's disease, pathological cardiac hypertrophy and diabetes [5].
loading...
    loading...
Cat. No.: HY-182820
CAS No.: 3086041-35-9
Research Areas:  

Cancer

YZ-836P is a Protein arginine methyltransferase 5 (PRMT5) targeting agent. YZ-836P promotes ubiquitination and proteasomal degradation of PRMT5 in a cereblon (CRBN)-dependent manner, which in turn reduces levels of its downstream target KLF5. YZ-836P induces G1 phase cell cycle arrest in triple-negative breast cancer cells. YZ-836P induces Apoptosis in triple-negative breast cancer cells. YZ-836P exerts cytotoxic effects on triple-negative breast cancer cells. YZ-836P inhibits the growth of triple-negative breast cancer patient-derived organoids. YZ-836P inhibits the growth of triple-negative breast cancer xenografts in nude mice. YZ-836P can be used for the research of triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-P87270
Synonyms: Basic transcription element binding protein 2 antibody; Basic transcription element-binding protein 2 antibody; BTE binding protein 2 antibody; BTE-binding protein 2 antibody; BTEB 2 antibody; BTEB2 antibody; CKLF antibody; Colon krueppel like factor antibody; Colon krueppel-like factor antibody; GC box binding protein 2 antibody

Host:  

Rabbit

Application:  

ICC/IF, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1